الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 185 |  |  |
| | | from | 185 | | |
Abstract
Background: Several countries have adopted national reporting systems of medication errors, such as the UK and the USA. A new national reporting system of medication errors (MEs) & drug therapy problems (DTPs), the National Office for Handling And Reduction of Medication errors (NOHARMe), was launched in some governmental Egyptian hospitals in October 2017.
Objectives: To determine clinical pharmacists’ perceptions regarding the characteristics of the new NOHARMe and identify the barriers to reporting they face during its use.
Subjects and Methods: A cross-sectional survey was done in 56 governmental hospitals where NOHARMe was implemented using a self-administered online questionnaire between October and November 2019.
Results: Most of the (206) respondents were females (96%), with a mean age of 32.8 years (SD 4.32); most reported detecting DTPs and MEs for all patients (85.4%), and reported every ME (86.4%), including near misses. They used NOHARMe sometimes to identify the causes of errors (57%) and provide feedback on the results of reports analysis (47%). Many users prepared medication management policies (70.4%), educational materials (89.3%), and protocols for rational drug use (74%). The users defined the barriers within NOHARMe; including the need to explain the role of clinical pharmacists to other healthcare providers, limited numbers of computer devices and internet connections, and the lengthy reporting.
Conclusion: NOHARMe allowed analyzing the reports, hence provided the opportunity to identify causes of error. The users recommended developing web-based software and a mobile application.